Click here to go to the previous page
Treatment of Localized Intermediate Risk Prostate Cancer
Program Code:
EDU314
Date:
Tuesday, September 23, 2008
SPEAKER(S):
I-Chow Hsu, Radiation Oncologist, University of California San Francisco Comprehensi
Dr. Andrew Lee, Associate Professor, M.D. Anderson Cancer Center
LEARNER OUTCOMES:
-
Define intermediate risk prostate cancer and its clinical implications.
-
Discuss the rationale and current methods for dose-escalation radiation therapy for this disease.
-
Explain the rationale and methods for combining hormonal therapy with radiation in this disease.